Pharmaceutical company Takeda JP:4502 announced Wednesday that the U.S. Food and Drug Administration has approved Fluzakura for the treatment of certain colorectal cancer patients.
Fluzacra (fruquintinib), an oral targeted therapy, has been approved for adults with metastatic colorectal cancer who have received certain prior treatments.
of…
Thanks for sharing. I read many of your blog posts, cool, your blog is very good.
Thank you for your sharing. I am worried that I lack creative ideas. It is your article that makes me full of hope. Thank you. But, I have a question, can you help me?